Loading stock data…
Cardinal Health, Inc. (CAH)
$240.49-6.69 (-2.71%)
Cardinal Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardinal Health, Inc. in the Healthcare sector is trading at $240.49 with a market capitalization of $45.9B. Wall Street consensus targets $270.94 (16 analysts), implying a +12.7% move over the next 12 months. The stock is currently near its 52-week high of $258.30, remaining 11.7% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +12.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $60.94B↓ | $65.63B↑ | $64.01B↑ | $60.16B↑ | $54.88B |
| Gross Profit | $2.50B↑ | $2.40B↑ | $2.32B↑ | $2.20B↑ | $2.12B |
| Operating Income | $842.00M↑ | $763.00M↑ | $754.00M↑ | $585.00M↓ | $656.00M |
| Net Income | $399.00M↓ | $467.00M↑ | $450.00M↑ | $239.00M↓ | $506.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$45.87B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.90
Beta
Defensive asset. Lower volatility than the S&P 500.
0.54
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.85%
ROE
Average efficiency. Growth may require heavy reinvestment.
-54.91%
Volume
Today's trading volume
1.58M
Recent News
Cardinal Health (CAH) Declines More Than Market: Some Information for Investors
In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates
McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo analyst Stephen Baxter. The company said Precision Medicine Group would expand two areas it has id
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”
On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]